Haemonetics Corporation (HAE)
USD 78.77
(-4.02%)
USD 78.77
(-4.02%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 117.55 Million USD | 1.87% |
| 2023 | 115.4 Million USD | 166.05% |
| 2022 | 43.37 Million USD | -45.42% |
| 2021 | 79.46 Million USD | 3.85% |
| 2020 | 76.52 Million USD | 39.09% |
| 2019 | 55.01 Million USD | 20.73% |
| 2018 | 45.57 Million USD | 273.49% |
| 2017 | -26.26 Million USD | 52.77% |
| 2016 | -55.62 Million USD | -429.17% |
| 2015 | 16.89 Million USD | -51.93% |
| 2014 | 35.14 Million USD | -9.41% |
| 2013 | 38.8 Million USD | -41.99% |
| 2012 | 66.88 Million USD | -16.37% |
| 2011 | 79.98 Million USD | 37.01% |
| 2010 | 58.37 Million USD | -1.57% |
| 2009 | 59.3 Million USD | 14.09% |
| 2008 | 51.98 Million USD | 5.85% |
| 2007 | 49.1 Million USD | -28.91% |
| 2006 | 69.07 Million USD | 74.26% |
| 2005 | 39.63 Million USD | 35.19% |
| 2004 | 29.32 Million USD | 3.32% |
| 2003 | 28.37 Million USD | -5.49% |
| 2002 | 30.02 Million USD | 314.97% |
| 2001 | 7.23 Million USD | -61.91% |
| 2000 | 18.99 Million USD | -9.96% |
| 1999 | 21.1 Million USD | 185.08% |
| 1998 | -24.8 Million USD | -175.15% |
| 1997 | 33 Million USD | -8.08% |
| 1996 | 35.9 Million USD | 6.85% |
| 1995 | 33.6 Million USD | 6.67% |
| 1994 | 31.5 Million USD | 27.02% |
| 1993 | 24.8 Million USD | 37.78% |
| 1992 | 18 Million USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 24.9 Million USD | -39.31% |
| 2024 Q4 | 20.36 Million USD | -34.81% |
| 2024 Q3 | 31.24 Million USD | 25.43% |
| 2024 FY | 117.55 Million USD | 1.87% |
| 2024 Q1 | 41.04 Million USD | 39.68% |
| 2023 Q1 | 19.87 Million USD | 104.06% |
| 2023 Q2 | 33.19 Million USD | 67.01% |
| 2023 Q3 | 32.94 Million USD | -0.76% |
| 2023 Q4 | 29.38 Million USD | -10.81% |
| 2023 FY | 115.4 Million USD | 166.05% |
| 2022 Q4 | 9.74 Million USD | -58.07% |
| 2022 FY | 43.37 Million USD | -45.42% |
| 2022 Q2 | 14.85 Million USD | 433.54% |
| 2022 Q3 | 23.23 Million USD | 56.38% |
| 2022 Q1 | -4.45 Million USD | 59.66% |
| 2021 Q3 | 31.88 Million USD | -33.72% |
| 2021 Q1 | 10.52 Million USD | -40.27% |
| 2021 Q2 | 48.1 Million USD | 356.93% |
| 2021 FY | 79.46 Million USD | 3.85% |
| 2021 Q4 | -11.04 Million USD | -134.63% |
| 2020 Q3 | 29.89 Million USD | -20.25% |
| 2020 Q2 | 37.48 Million USD | 542.1% |
| 2020 Q4 | 17.62 Million USD | -41.05% |
| 2020 FY | 76.52 Million USD | 39.09% |
| 2020 Q1 | -8.47 Million USD | -140.7% |
| 2019 Q2 | 18.72 Million USD | 764.28% |
| 2019 Q4 | 20.83 Million USD | 14.0% |
| 2019 Q3 | 18.27 Million USD | -2.4% |
| 2019 Q1 | -2.81 Million USD | -123.73% |
| 2019 FY | 55.01 Million USD | 20.73% |
| 2018 Q2 | 20.1 Million USD | -0.17% |
| 2018 FY | 45.57 Million USD | 273.49% |
| 2018 Q4 | 11.88 Million USD | 281.46% |
| 2018 Q1 | 20.13 Million USD | 139.38% |
| 2018 Q3 | -6.54 Million USD | -132.57% |
| 2017 Q1 | -10.34 Million USD | -17.89% |
| 2017 FY | -26.26 Million USD | 52.77% |
| 2017 Q2 | 19.82 Million USD | 291.62% |
| 2017 Q4 | -51.14 Million USD | -432.23% |
| 2017 Q3 | 15.39 Million USD | -22.36% |
| 2016 Q3 | -59.44 Million USD | -562.1% |
| 2016 FY | -55.62 Million USD | -429.17% |
| 2016 Q1 | -267 Thousand USD | 90.89% |
| 2016 Q4 | -8.77 Million USD | 85.24% |
| 2016 Q2 | 12.86 Million USD | 4917.6% |
| 2015 Q1 | -3.64 Million USD | -135.83% |
| 2015 Q4 | -2.93 Million USD | -118.33% |
| 2015 Q3 | 15.98 Million USD | 113.54% |
| 2015 FY | 16.89 Million USD | -51.93% |
| 2015 Q2 | 7.48 Million USD | 305.18% |
| 2014 Q1 | -7.87 Million USD | -162.69% |
| 2014 FY | 35.14 Million USD | -9.41% |
| 2014 Q3 | 16.29 Million USD | -1.56% |
| 2014 Q2 | 16.54 Million USD | 310.16% |
| 2014 Q4 | 10.18 Million USD | -37.48% |
| 2013 Q3 | 9.9 Million USD | 51.28% |
| 2013 Q2 | 6.54 Million USD | -33.11% |
| 2013 Q1 | 9.78 Million USD | -45.04% |
| 2013 FY | 38.8 Million USD | -41.99% |
| 2013 Q4 | 12.56 Million USD | 26.83% |
| 2012 Q2 | 13.88 Million USD | -18.1% |
| 2012 Q3 | 18.25 Million USD | 31.5% |
| 2012 Q4 | 17.8 Million USD | -2.44% |
| 2012 Q1 | 16.94 Million USD | -19.25% |
| 2012 FY | 66.88 Million USD | -16.37% |
| 2011 Q3 | 19.73 Million USD | -7.52% |
| 2011 Q1 | 17.91 Million USD | 352.36% |
| 2011 Q2 | 21.33 Million USD | 19.09% |
| 2011 FY | 79.98 Million USD | 37.01% |
| 2011 Q4 | 20.98 Million USD | 6.35% |
| 2010 Q2 | 18.05 Million USD | -0.13% |
| 2010 Q1 | 18.07 Million USD | 29.66% |
| 2010 FY | 58.37 Million USD | -1.57% |
| 2010 Q4 | 3.96 Million USD | -78.34% |
| 2010 Q3 | 18.28 Million USD | 1.31% |
| 2009 Q3 | 16.21 Million USD | 9.52% |
| 2009 Q2 | 14.8 Million USD | 3.25% |
| 2009 Q4 | 13.93 Million USD | -14.04% |
| 2009 Q1 | 14.34 Million USD | 4.06% |
| 2009 FY | 59.3 Million USD | 14.09% |
| 2008 FY | 51.98 Million USD | 5.85% |
| 2008 Q4 | 13.78 Million USD | -3.99% |
| 2008 Q3 | 14.35 Million USD | 28.54% |
| 2008 Q1 | 12.67 Million USD | -35.93% |
| 2008 Q2 | 11.16 Million USD | -11.91% |
| 2007 Q1 | 11.3 Million USD | -34.09% |
| 2007 FY | 49.1 Million USD | -28.91% |
| 2007 Q4 | 19.78 Million USD | 17.06% |
| 2007 Q3 | 16.9 Million USD | 1235.07% |
| 2007 Q2 | 1.26 Million USD | -88.8% |
| 2006 Q2 | 10.94 Million USD | -15.05% |
| 2006 Q1 | 12.88 Million USD | 29.64% |
| 2006 FY | 69.07 Million USD | 74.26% |
| 2006 Q4 | 17.15 Million USD | -38.92% |
| 2006 Q3 | 28.08 Million USD | 156.64% |
| 2005 Q2 | 8.87 Million USD | -9.63% |
| 2005 FY | 39.63 Million USD | 35.19% |
| 2005 Q1 | 9.82 Million USD | 3.06% |
| 2005 Q3 | 11 Million USD | 24.04% |
| 2005 Q4 | 9.93 Million USD | -9.71% |
| 2004 FY | 29.32 Million USD | 3.32% |
| 2004 Q2 | 5.49 Million USD | 10.27% |
| 2004 Q4 | 9.52 Million USD | 2.3% |
| 2004 Q1 | 4.98 Million USD | 11.3% |
| 2004 Q3 | 9.31 Million USD | 69.5% |
| 2003 Q4 | 4.47 Million USD | -56.73% |
| 2003 FY | 28.37 Million USD | -5.49% |
| 2003 Q3 | 10.34 Million USD | 52.61% |
| 2003 Q2 | 6.78 Million USD | 0.07% |
| 2003 Q1 | 6.77 Million USD | -12.05% |
| 2002 FY | 30.02 Million USD | 314.97% |
| 2002 Q2 | 9.94 Million USD | 0.04% |
| 2002 Q1 | 9.94 Million USD | 38.75% |
| 2002 Q3 | 2.43 Million USD | -75.55% |
| 2002 Q4 | 7.7 Million USD | 216.74% |
| 2001 FY | 7.23 Million USD | -61.91% |
| 2001 Q1 | 6.66 Million USD | 735.09% |
| 2001 Q2 | -15.11 Million USD | -326.88% |
| 2001 Q3 | 8.96 Million USD | 159.28% |
| 2001 Q4 | 7.16 Million USD | -20.04% |
| 2000 Q3 | 6.5 Million USD | 14.04% |
| 2000 FY | 18.99 Million USD | -9.96% |
| 2000 Q4 | 798 Thousand USD | -87.72% |
| 2000 Q1 | 6 Million USD | -1.64% |
| 2000 Q2 | 5.7 Million USD | -5.0% |
| 1999 Q1 | 4.9 Million USD | 120.76% |
| 1999 FY | 21.1 Million USD | 185.08% |
| 1999 Q4 | 6.1 Million USD | 27.08% |
| 1999 Q3 | 4.8 Million USD | -9.43% |
| 1999 Q2 | 5.3 Million USD | 8.16% |
| 1998 Q4 | -23.6 Million USD | -101.71% |
| 1998 FY | -24.8 Million USD | -175.15% |
| 1998 Q1 | 6.5 Million USD | -17.72% |
| 1998 Q2 | 4 Million USD | -38.46% |
| 1998 Q3 | -11.7 Million USD | -392.5% |
| 1997 Q1 | 9.4 Million USD | 3.3% |
| 1997 Q4 | 7.9 Million USD | 12.86% |
| 1997 Q3 | 7 Million USD | -18.6% |
| 1997 Q2 | 8.6 Million USD | -8.51% |
| 1997 FY | 33 Million USD | -8.08% |
| 1996 Q2 | 9.2 Million USD | 5.75% |
| 1996 Q1 | 8.7 Million USD | 2.35% |
| 1996 Q3 | 8.9 Million USD | -3.26% |
| 1996 FY | 35.9 Million USD | 6.85% |
| 1996 Q4 | 9.1 Million USD | 2.25% |
| 1995 Q4 | 8.5 Million USD | 0.0% |
| 1995 Q1 | 8.1 Million USD | -3.57% |
| 1995 Q2 | 8.5 Million USD | 4.94% |
| 1995 Q3 | 8.5 Million USD | 0.0% |
| 1995 FY | 33.6 Million USD | 6.67% |
| 1994 Q2 | 8 Million USD | 17.65% |
| 1994 Q1 | 6.8 Million USD | -2.86% |
| 1994 FY | 31.5 Million USD | 27.02% |
| 1994 Q4 | 8.4 Million USD | 1.2% |
| 1994 Q3 | 8.3 Million USD | 3.75% |
| 1993 Q3 | 6.6 Million USD | 10.0% |
| 1993 Q4 | 7 Million USD | 6.06% |
| 1993 FY | 24.8 Million USD | 37.78% |
| 1993 Q1 | 5.2 Million USD | -7.14% |
| 1993 Q2 | 6 Million USD | 15.38% |
| 1992 Q3 | 4.6 Million USD | 6.98% |
| 1992 Q4 | 5.6 Million USD | 21.74% |
| 1992 Q2 | 4.3 Million USD | 22.86% |
| 1992 FY | 18 Million USD | 0.0% |
| 1992 Q1 | 3.5 Million USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alcon Inc. | 974 Million USD | 87.93% |
| AptarGroup, Inc. | 284.48 Million USD | 58.677% |
| Baxter International Inc. | 2.65 Billion USD | 95.574% |
| Becton, Dickinson and Company | 1.72 Billion USD | 93.189% |
| Bausch + Lomb Corporation | -260 Million USD | 145.215% |
| Envista Holdings Corp | -100.2 Million USD | 217.323% |
| ResMed Inc. | 1.02 Billion USD | 88.485% |
| Teleflex Incorporated | 356.32 Million USD | 67.008% |
| Warby Parker Inc. | -63.19 Million USD | 286.018% |
| West Pharmaceutical Services, Inc. | 593.4 Million USD | 80.189% |